Neurological Alliance Report Calls for Better Treatment, Care for UK Patients
SMA News Today’s multimedia associate, Price Wooldridge, discusses a Neurological Alliance report calling for better treatment and care of U.K. patients living with rare neurological conditions such a...
14 Joulu 20207min
Spinraza Linked to Temporary Abnormalities in Immune Cells in 2 SMA Infants
SMA News Today’s multimedia associate, Price Wooldridge, discusses how Spinraza is linked to temporary abornalities in immune cells in two Spinal Muscular Atrophy (SMA) infants. SMA News Today’s foru...
11 Joulu 20209min
Extensive Trial Monitoring Confirms Evrysdi Does Not Damage Vision & The Series "Boy Meets World"
SMA News Today’s multimedia associate, Price Wooldridge, discusses how extensive trial monitoring confirms Evrysdi does not damage vision in children or adults with Spinal Muscular Atrophy (SMA). SMA...
9 Joulu 202011min
Olesoxime Failed to Benefit SMA Type 2 and 3 Patients, Final Trial Data Show
SMA News Today’s multimedia associate, Price Wooldridge, discusses how olesoxime failed to benefit Spinal Muscular Atrophy (SMA) Type 2 and 3 patients in a final trial. SMA News Today’s forums moder...
7 Joulu 20209min
Gene Therapy Given Directly to Spinal Canal Might Be Safer With ‘Silencing’ Step
SMA News Today’s multimedia associate, Price Wooldridge, discusses how gene therapy, given directly to the spinal canal, might be safer with a “silencing” step. SMA News Today’s forums moderator, DeA...
4 Joulu 202010min
Exploring The Intersection of Identity and SMA
Forums Director Kevin Schaefer explores the intersection of identity and SMA in his latest column. To learn more about spinal muscular atrophy, visit our website at www.smanewstoday.com.
2 Joulu 20204min
#71: Interview with Kristen Resendez, SMA Parent and Advocate
In episode 71, host Kevin Schaefer talks with Kristen Resendez from Harlingen, Texas. Kristen’s son, Jack, has SMA, and she is an active member of the SMA community. During this conversation, she talk...
1 Joulu 202040min
Spinraza Shown to Preserve Respiratory Muscle Strength in SMA Type 2 Patients
SMA News Today’s multimedia associate, Price Wooldridge, discusses how a study has shown Spinraza preserves respiratory muscle strength in Spinal Muscular Atrophy (SMA) Type 2 patients. Are you inter...
30 Marras 20205min
